yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33258048-2ACA5C4A-0B7E-4C76-AB6B-01D19490B6AC
Q33258048-2ACA5C4A-0B7E-4C76-AB6B-01D19490B6AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33258048-2ACA5C4A-0B7E-4C76-AB6B-01D19490B6AC
Evaluation of efalizumab using safe psoriasis control.
P2860
Q33258048-2ACA5C4A-0B7E-4C76-AB6B-01D19490B6AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33258048-2ACA5C4A-0B7E-4C76-AB6B-01D19490B6AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eeeb3b9a76c503b7fe1a7a426b7a9f4f71de87e3
P2860
Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.